CC
GSK icon

Callan Capital’s GSK GSK Stock Holding History

Callan Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$519K Buy
13,401
+3,714
+38% +$136K 0.04% 198
2024
Q4 		$328K Buy
9,687
+2,940
+44% +$106K 0.02% 242
2024
Q3 		$276K Sell
6,747
-151
-2% -$6.18K 0.02% 279
2024
Q2 		$266K Buy
6,898
+985
+17% +$41.4K 0.02% 252
2024
Q1 		$253K Buy
+5,913
New +$244K 0.02% 232

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Callan Capital's GSK Position: Q1 2025 in Review

Callan Capital increased its GSK (GSK) stake by 38% in Q1 2025, buying an estimated $136K and bringing the position to 13,401 shares worth $519K. The position accounts for 0.04% of the portfolio, ranked #198.

Callan Capital first reported a position in GSK in Q1 2024 and has held it in 5 quarters since. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Callan Capital held 13,401 shares of GSK worth $519K as of Q1 2025.
  • Callan Capital bought 3,714 GSK shares in Q1 2025, an estimated $136K.
  • GSK made up 0.04% of Callan Capital's portfolio in Q1 2025, its #198 holding.
  • Callan Capital first reported a position in GSK in Q1 2024 and has held it in 5 quarters since.
  • 857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.